NYSE:ACN • IE00B4BNMY34
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACCENTURE PLC-CL A (ACN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-23 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-20 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-20 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2026-03-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-03-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-20 | Baird | Maintains | Outperform -> Outperform |
| 2026-03-19 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-16 | TD Cowen | Maintains | Buy -> Buy |
| 2026-03-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-03-11 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-10 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-17 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-01-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-06 | Truist Securities | Initiate | Buy |
| 2025-12-19 | UBS | Maintains | Buy -> Buy |
| 2025-12-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-19 | Susquehanna | Maintains | Neutral -> Neutral |
| 2025-12-16 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-10-22 | Wells Fargo | Initiate | Equal-Weight |
| 2025-10-22 | Citigroup | Initiate | Neutral |
| 2025-09-29 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-26 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-26 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-26 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.112B 4.09% | 64.896B 1.22% | 69.673B 7.36% | 74.86B 7.44% | 78.871B 5.36% | 83.717B 6.14% | 89.84B 7.31% | 95.761B 6.59% | |
| EBITDA YoY % growth | 12.154B 6.10% | 12.202B 0.40% | 13.283B 8.85% | 14.234B 7.16% | 15.257B 7.19% | 16.404B 7.52% | 16.53B 0.77% | 16.942B 2.49% | |
| EBIT YoY % growth | 9.873B 5.40% | 10.034B 1.63% | 10.841B 8.04% | 11.731B 8.21% | 12.521B 6.73% | 13.428B 7.24% | 15.02B 11.86% | 15.403B 2.55% | |
| Operating Margin | 15.40% | 15.46% | 15.56% | 15.67% | 15.88% | 16.04% | 16.72% | 16.08% | |
| EPS YoY % growth | 11.67 7.46% | 11.96 2.49% | 12.93 8.11% | 13.98 8.16% | 15.08 7.86% | 16.44 8.99% | 18.47 12.34% | 19.18 3.88% |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.76 7.86% | 3.32 9.60% | 4.09 3.93% | 3.28 12.11% | 4.10 8.82% | 3.66 10.36% | 4.42 7.98% | 3.59 9.31% | 4.44 8.41% | 4.03 9.96% |
| Revenue Q2Q % growth | 19.004B 7.20% | 18.719B 6.38% | 19.883B 6.09% | 19.211B 6.47% | 19.96B 5.03% | 19.736B 5.43% | 21.041B 5.82% | 20.274B 5.53% | 20.864B 4.53% | 20.979B 6.30% |
| EBITDA Q2Q % growth | 3.851B -17.46% | 3.519B -31.09% | 4.038B 7.31% | 3.339B -8.79% | 4.038B 4.86% | 3.684B 4.69% | 4.303B 6.56% | 3.424B 2.55% | 4.286B 6.14% | 3.899B 5.84% |
| EBIT Q2Q % growth | 3.208B 7.55% | 2.862B 7.39% | 3.388B 6.50% | 2.701B 8.32% | 3.391B 5.70% | 3.065B 7.09% | 3.603B 6.35% | 2.91B 7.74% | 3.608B 6.40% | 3.274B 6.82% |
All data in USD
34 analysts have analysed ACN and the average price target is 261.56 USD. This implies a price increase of 40.6% is expected in the next year compared to the current price of 186.03.
ACCENTURE PLC-CL A (ACN) will report earnings on 2026-06-18, before the market open.
The consensus EPS estimate for the next earnings of ACCENTURE PLC-CL A (ACN) is 3.76 USD and the consensus revenue estimate is 19.00B USD.
The expected long term growth rate for ACCENTURE PLC-CL A (ACN) is 6.08%.